2,133
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years

, , , , , , , , , , , , , , , , , , , , , , ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Article: 2246602 | Received 23 Apr 2023, Accepted 21 Jul 2023, Published online: 14 Aug 2023